|Articles|August 2, 2003
- Pharmaceutical Technology-08-02-2003
- Volume 27
- Issue 8
New FDA Initiatives Aim to Spur Innovation
Author(s)Jill Wechsler
Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.
Advertisement
Articles in this issue
almost 23 years ago
BIO Updatealmost 23 years ago
Designing Transfer Carts for Class 100 Conditionsalmost 23 years ago
An Update on Osmotic Drug Deliveryalmost 23 years ago
Interphex Serves as a Showcase for New Materials and Machinesalmost 23 years ago
August 2003almost 23 years ago
In the Spotlight August 2003Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
2
FDA Approves Pfizer’s Breast Cancer Treatment
3
Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value
4
Pharma Fundamentals: Hold Times in Biopharmaceuticals
5